| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.08▲ | 7.05▲ | 6.99▲ | 6.53▲ | 6.43▲ |
| MA10 | 7.05▲ | 6.93▲ | 6.86▲ | 6.11▲ | 5.43▲ |
| MA20 | 7.05▲ | 6.85▲ | 6.73▲ | 6.33▲ | 4.85▲ |
| MA50 | 6.92▲ | 6.57▲ | 6.31▲ | 5.08▲ | 5.06▲ |
| MA100 | 6.84▲ | 6.26▲ | 6.19▲ | 4.80▲ | 6.34▲ |
| MA200 | 6.66▲ | 6.21▲ | 5.91▲ | 5.07▲ | 15.75▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.015▲ | 0.020▲ | 0.024▲ | 0.329▲ |
| RSI | 67.081▲ | 68.013▲ | 72.959▲ | 68.181▲ | 65.902▲ |
| STOCH | 92.956▲ | 86.840▲ | 78.112 | 71.544 | 73.560 |
| WILL %R | 0.000▲ | -3.175▲ | -2.899▲ | -2.196▲ | -11.330▲ |
| CCI | 151.905▲ | 102.257▲ | 147.614▲ | 143.493▲ | 122.879▲ |
|
Wednesday, April 08, 2026 07:01 AM
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
|
|
Wednesday, April 08, 2026 07:01 AM
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
|
|
Wednesday, March 11, 2026 12:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/04/26 | 6.62 | 7.17 | 6.51 | 7.13 | 217,958 |
| 10/04/26 | 6.63 | 6.96 | 6.45 | 6.67 | 423,302 |
| 09/04/26 | 5.99 | 6.61 | 5.96 | 6.61 | 207,948 |
| 08/04/26 | 6.42 | 6.50 | 5.675 | 5.99 | 417,585 |
| 07/04/26 | 6.01 | 6.40 | 5.73 | 6.26 | 271,967 |
| 06/04/26 | 5.83 | 6.22 | 5.82 | 6.01 | 196,881 |
| 02/04/26 | 5.68 | 6.15 | 5.61 | 5.82 | 303,809 |
| 01/04/26 | 5.45 | 5.785 | 5.45 | 5.69 | 121,216 |
| 31/03/26 | 5.45 | 5.83 | 5.3487 | 5.50 | 152,323 |
| 30/03/26 | 5.95 | 5.95 | 5.41 | 5.42 | 255,554 |
|
|
||||
|
|
||||
|
|